Oligonucleotide Synthesis Market Updates : is Anticipated to Surpass USD 26.099 Billion by 2030 ; at 17.1% CAGR

Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market

The global oligonucleotide synthesis market is projected to reach $ 26.099 billion by 2030 registering a CAGR of 17.10% from 2021 to 2030.

Oligonucleotide Synthesis Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, Application and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030. ”
— Allied Market Research

WILMINGTON, DELAWARE , UNITED STATES, April 3, 2024 /EINPresswire.com/ -- Allied Market Research recently published a report, titled, "Oligonucleotide Synthesis Market by Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, and Equipment), Application (Therapeutic Applications, Research Applications, and Diagnostic Applications) and End User (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021โ€“2030". As per the report, the global oligonucleotide synthesis industry was pegged at $5.19 billion in 2020, and is expected to reach $26.09 billion by 2030, growing at a CAGR of 17.1% from 2021 to 2030.

๐‘น๐’†๐’’๐’–๐’†๐’”๐’• ๐‘บ๐’‚๐’Ž๐’‘๐’๐’† ๐‘ช๐’๐’‘๐’š ๐’๐’‡ ๐‘น๐’†๐’‘๐’๐’“๐’• https://www.alliedmarketresearch.com/request-sample/A08356

๐‘ด๐’‚๐’‹๐’๐’“ ๐’…๐’†๐’•๐’†๐’“๐’Ž๐’Š๐’๐’‚๐’๐’•๐’” ๐’๐’‡ ๐’•๐’‰๐’† ๐’Ž๐’‚๐’“๐’Œ๐’†๐’• ๐’ˆ๐’“๐’๐’˜๐’•๐’‰
The global oligonucleotide synthesis market is experiencing growth due to increased government investments and R&D spending in pharmaceutical and biotechnology sectors, alongside a rise in the use of synthesized oligonucleotides in molecular diagnostics and clinical applications. The demand for high-end customized oligos and advancements in purification methods are further driving market expansion. However, challenges such as delivering oligonucleotide drugs to specific targets and complexities associated with therapeutic oligos are impeding growth. Nevertheless, there are promising opportunities on the horizon, including a growing focus on personalized medicines and untapped potential in developing economies, which could benefit market players in the future.

๐‘ป๐’‰๐’† ๐’”๐’š๐’๐’•๐’‰๐’†๐’”๐’Š๐’›๐’†๐’… ๐’๐’๐’Š๐’ˆ๐’๐’๐’–๐’„๐’๐’†๐’๐’•๐’Š๐’…๐’†๐’” ๐’”๐’†๐’ˆ๐’Ž๐’†๐’๐’• ๐’•๐’ ๐’Ž๐’‚๐’๐’Š๐’‡๐’†๐’”๐’• ๐’•๐’‰๐’† ๐’‰๐’Š๐’ˆ๐’‰๐’†๐’”๐’• ๐‘ช๐‘จ๐‘ฎ๐‘น ๐’•๐’‰๐’“๐’๐’–๐’ˆ๐’‰ 2030
During the forecast period, the synthesized oligonucleotides segment is anticipated to exhibit the highest compound annual growth rate (CAGR) of 18.1%, primarily fueled by increased utilization across various domains such as molecular diagnosis and clinical applications. However, in 2020, the oligonucleotide-based drugs segment dominated the market, capturing over one-third of the global oligonucleotide synthesis market share. This was attributed to the growing number of FDA-approved drugs and the expanding clinical pipeline for oligonucleotide-based medications.

๐‘ป๐’‰๐’† ๐’•๐’‰๐’†๐’“๐’‚๐’‘๐’†๐’–๐’•๐’Š๐’„ ๐’”๐’†๐’ˆ๐’Ž๐’†๐’๐’• ๐’…๐’๐’Ž๐’Š๐’๐’‚๐’•๐’†๐’… ๐’•๐’‰๐’† ๐’Ž๐’‚๐’“๐’Œ๐’†๐’•
In 2020, the therapeutic segment accounted for the largest share, representing approximately two-fifths of the global oligonucleotide synthesis market, driven by increased research into therapeutic applications. However, during the forecast period, the research segment is expected to demonstrate the highest compound annual growth rate (CAGR) of 17.6%. This growth is attributed to the increasing approval of numerous drugs in recent years.

๐‘ด๐’‚๐’‹๐’๐’“ ๐’Ž๐’‚๐’“๐’Œ๐’†๐’• ๐’‘๐’๐’‚๐’š๐’†๐’“๐’”
Alnylam Pharmaceuticals, Inc.
Danaher Corporation
Biogen Inc.
Ionis Pharmaceuticals, Inc.
Eurofins Scientific
LGC Limited
Kaneka Corporation
Sarepta Therapeutics, Inc.
Merck KGAA
Thermo Fisher Scientific, Inc.

๐‘ซ๐’ ๐‘ท๐’–๐’“๐’„๐’‰๐’‚๐’”๐’† ๐‘ฌ๐’๐’’๐’–๐’Š๐’“๐’š https://www.alliedmarketresearch.com/purchase-enquiry/A08356

๐‘ฒ๐’†๐’š ๐‘ญ๐’Š๐’๐’…๐’Š๐’๐’ˆ๐’” ๐’๐’‡ ๐’•๐’‰๐’† ๐‘บ๐’•๐’–๐’…๐’š
Based on product, the oligonucleotide-based drugs held the largest share in the global market in 2020.
On the basis of application, the therapeutic application held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
By end user, the hospitals segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 16.00% during the forecast period.

๐‘ญ๐’“๐’†๐’’๐’–๐’†๐’๐’•๐’๐’š ๐‘จ๐’”๐’Œ๐’†๐’… ๐‘ธ๐’–๐’†๐’”๐’•๐’Š๐’๐’๐’”?
Which are the top companies hold the market share in Oligonucleotide synthesis market?
Which is the most influencing segment growing in the Oligonucleotide synthesis report?
What are the key trends in the Oligonucleotide synthesis market report?
What are the market values / growth % of emerging countries?
What is the market value of Oligonucleotide synthesis market in 2021?

David Correa
Allied Market Research
+1 5038946022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn